Piramal Pharma posts robust Q2 growth, expands Lexington facility to meet demand

Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635) has reported strong growth for the second quarter (Q2) and first half (H1) of the fiscal year ... Read More